Navigation Links
International Human Rights Day Recognized by Terasem Movement, Inc.'s Third Annual Colloquium on the Law of Transbeman Persons
Date:12/3/2007

Public Invited Via Conference Call on December 10, 2007

SPACE COAST, Fla., Dec. 3 /PRNewswire-USNewswire/ -- Terasem Movement, Incorporated announced today that its Third Annual Colloquium on the Law of Transbeman Persons, in celebration of International Human Rights Day, will be held December 10, 2007 along Florida's Space Coast. A transbeman is a bio-electronic human transitioning between flesh and computerized substrate.

The colloquia are open to the public via real-time conference call and blogging and will be archived online for free public access. The public is invited to call a toll-free conference-call dial-in line from 9:00 a.m. - 5:00 p.m. EST. Callers within the continental U.S. and Canada may dial 1-877-879-6207; other countries: (00+1) 1-719-325-4775 or access the blog at: http://acceleratingfuture.com/michael/blog/.

Colloquium presentations are designed for a 15-20 minute delivery, followed by a 20-minute discussion period amongst attendees. Additional questions from the worldwide audience will also be invited. Presentations will also be available on the Colloquium's website at: http://www.terasemcentral.org/TL/2007ColloquiumProgram.html.

This year's speakers by order of presentation are: Dr. Marvin Minsky, MIT, Author: The Emotion Machine; David R. Koepsell, J.D., Ph.D., Yale Interdisciplinary Center for Bioethics; William Sims Bainbridge, Ph.D., National Science Foundation; Linda MacDonald-Glenn, J.D., LLM, Alden March Bioethics Institute and University of Vermont College of Nursing and Health Sciences; Max More, Ph.D., Co-founder of the Extropy Institute; Sebastian Sethe, Sheffield Institute of Biotechnological Law & Ethics; R. Michael Perry, Author: Toward Self-Optimization of Machine; and Prof. Gene Natale, J.D., Keiser University.

Real-time blogging provided by Michael Anissimov, Lifeboat Foundation's North American Fundraising Director. http://www.lifeboat.com

For additional information, please contact: Loraine J. Rhodes at 321-676-3690, ext 100, or lori@terasemcentral.org.

About the Terasem Movement

The Terasem Movement, Inc., is a 501(c)(3) not-for-profit charity endowed for the purpose of educating the public on the practicality and necessity of greatly extending human life, consistent with diversity and unity, via geoethical nanotechnology and personal cyberconsciousness. The Terasem Movement accomplishes its objectives by convening publicly accessible symposia, publishing explanatory analyses, conducting demonstration projects, issuing grants and encouraging public belief in a positive, technologically-based future.

For more information, please visit http://www.terasemcentral.org or http://terasemfoundation.org.


'/>"/>
SOURCE Terasem Movement Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
3. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
4. Arrow International Files and Mails Definitive Proxy Materials
5. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Viragen International to Reverse Split Its Common Stock
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
10. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
11. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):